Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
Kiho Son, Rameen Jamil, Abhiroop Chowdhury, et al.
European Respiratory Journal (2022), pp. 2200970-2200970
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 265
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 180
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort
Viet-Thi Tran, Élodie Perrodeau, Júlia Schirmer Saldanha, et al.
BMJ Medicine (2023) Vol. 2, Iss. 1, pp. e000229-e000229
Open Access | Times Cited: 91
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 87
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort
Franziska Legler, Lil Meyer-Arndt, Lukas Mödl, et al.
EClinicalMedicine (2023) Vol. 63, pp. 102146-102146
Open Access | Times Cited: 58
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 47
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 38
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Al Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 33
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
Kirsten Baillie, Helen Davies, Samuel Keat, et al.
Med (2024) Vol. 5, Iss. 3, pp. 239-253.e5
Open Access | Times Cited: 24
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 23
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
Mónika Fekete, Andrea Ceglédi, Ágnes Szappanos, et al.
GeroScience (2025)
Open Access | Times Cited: 2
Molecular mimicry and autoimmunity in the time of COVID-19
Manuel Rojas, María Herrán, Carolina Ramírez‐Santana, et al.
Journal of Autoimmunity (2023) Vol. 139, pp. 103070-103070
Open Access | Times Cited: 39
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients
Aaron Bodansky, Chung‐Yu Wang, Aditi R. Saxena, et al.
JCI Insight (2023) Vol. 8, Iss. 11
Open Access | Times Cited: 36
Diagnosis and management of post-COVID (Long COVID) in children: a moving target
Rosa Morello, Laura Martino, Danilo Buonsenso
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 2, pp. 184-192
Open Access | Times Cited: 35
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Fighting Post-COVID and ME/CFS – development of curative therapies
Carmen Scheibenbogen, Judith Bellmann‐Strobl, Cornelia Heindrich, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 34
Long COVID-19 Pathophysiology: What Do We Know So Far?
Nikolaos Tziolos, Πέτρος Ιωάννου, Stella Baliou, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 34
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 33
Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
Danilo Buonsenso, Laura Martino, Rosa Morello, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e745-e756
Open Access | Times Cited: 32
Immunological profiling in long COVID: overall low grade inflammation and T-lymphocyte senescence and increased monocyte activation correlating with increasing fatigue severity
Julia C. Berentschot, Hemmo A. Drexhage, D Mersha, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID
Nicholas A. Scott, Laurence Pearmain, Sean Knight, et al.
European Respiratory Journal (2023) Vol. 61, Iss. 5, pp. 2202226-2202226
Open Access | Times Cited: 28
COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark
Qing Shen, Emily E. Joyce, Omid V. Ebrahimi, et al.
The Lancet Regional Health - Europe (2023) Vol. 35, pp. 100756-100756
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top